FOXO4-DRI
10mg
Illustrative packaging
FOXO4-DRI
Synthetic senolytic peptide researched for selectively eliminating senescent cells.
Online ordering is not open yet. Contact us to confirm availability and quantity.
FOXO4-DRI (Proxofim) is a synthetic senolytic peptide researched for selectively eliminating senescent cells through disruption of the FOXO4–p53 interaction. By blocking this interaction, it allows p53 to translocate and trigger apoptosis in aged dysfunctional cells while healthy cells are largely spared. It is studied in healthy ageing, longevity and cellular senescence research.
Research Applications
Related Compounds
Semax
10mg
Illustrative packaging
Semax
ACTH analogue — studied for cognitive function, BDNF levels, and neuroprotection.
Epithalon
10mg · 50mg
Illustrative packaging
Epithalon
AEDG tetrapeptide — studied for telomere length and cellular ageing research.
NAD+
500mg · 1000mg
Illustrative packaging
NAD+
Nicotinamide adenine dinucleotide — studied for cellular energy production and healthy ageing.
Thymosin Alpha-1
10mg
Illustrative packaging
Thymosin Alpha-1
Thymic peptide — studied for immune cell activation and T-lymphocyte regulation.